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Background: The decision of when to stop septic shock resuscitation is a critical but yet a relatively unexplored aspect
of care. This is especially relevant since the risks of over-resuscitation with fluid overload or inotropes have been
highlighted in recent years. A recent guideline has proposed normalization of central venous oxygen saturation and/or
lactate as therapeutic end-points, assuming that these variables are equivalent or interchangeable. However, since the
physiological determinants of both are totally different, it is legitimate to challenge the rationale of this proposal. We
designed this study to gain more insights into the most appropriate resuscitation goal from a dynamic point of view.
Our objective was to compare the normalization rates of these and other potential perfusion-related targets in a cohort
of septic shock survivors.
Methods: We designed a prospective, observational clinical study. One hundred and four septic shock patients
with hyperlactatemia were included and followed until hospital discharge. The 84 hospital-survivors were kept for
final analysis. A multimodal perfusion assessment was performed at baseline, 2, 6, and 24 h of ICU treatment.
Results: Some variables such as central venous oxygen saturation, central venous-arterial pCO2 gradient, and
capillary refill time were already normal in more than 70% of survivors at 6 h. Lactate presented a much slower
normalization rate decreasing significantly at 6 h compared to that of baseline (4.0 [3.0 to 4.9] vs. 2.7 [2.2 to 3.9]
mmol/L; p < 0.01) but with only 52% of patients achieving normality at 24 h. Sublingual microcirculatory variables
exhibited the slowest recovery rate with persistent derangements still present in almost 80% of patients at 24 h.
Conclusions: Perfusion-related variables exhibit very different normalization rates in septic shock survivors, most
of them exhibiting a biphasic response with an initial rapid improvement, followed by a much slower trend
thereafter. This fact should be taken into account to determine the most appropriate criteria to stop resuscitation
opportunely and avoid the risk of over-resuscitation.
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Several clinical studies have demonstrated that persistent
impairment of perfusion-related physiological variables is
associated with increased mortality in septic shock pa-
tients [1-3]. Therefore, current guidelines recommend
normalization of relevant physiologic variables such as lac-
tate and/or central venous oxygen saturation (ScvO2) as
resuscitation goals, basically through oxygen transport* Correspondence: glennguru@gmail.com
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in any medium, provided the original work is p(DO2) optimization [4,5]. In addition, peripheral perfu-
sion, central venous-arterial pCO2 gradient (P(cv-a)CO2),
and microcirculatory abnormalities have also been linked
to morbidity or mortality and suggested as potential com-
plementary targets [6-8].
However, the issue of when to stop resuscitation has be-
come more relevant in recent years as the risks of over-
resuscitation have also been increasingly highlighted. In
fact, pursuing complete normalization of all potential
perfusion-related goals with repeated attempts to increase
DO2 could eventually result in severe adverse effects such
as fluid overload, pulmonary edema, intra-abdominals is an Open Access article distributed under the terms of the Creative Commons
g/licenses/by/4.0), which permits unrestricted use, distribution, and reproduction
roperly credited.
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mia, thus possibly increasing morbidity and mortality
[9-11].
From a physiological point of view, the problem is far
more complex. For instance, it is not known if all
perfusion-related variables are equally sensitive to DO2
optimization [12], a factor that could critically influence
their specific normalization rates. Besides, parameters
traditionally considered as reflecting tissue perfusion like
lactate are also mechanistically determined by non-flow
dependent or mixed mechanisms [13]. This may result
in a wide variability on individual recovery time courses
after optimization of DO2 depending on the predomin-
ant pathogenic mechanism. The practical aspect is that
if a more likely flow-dependent parameter is selected as
a goal (such as P(cv-a)CO2 or ScvO2), it may normalize
earlier than a less flow-dependent one such as lactate. In
other words, from a theoretical point of view, the resus-
citation length could vary dramatically depending on
these considerations leading eventually to the risk of
over-resuscitation if the selected goal exhibits an intrin-
sic slow normalization rate.
To address this subject, we designed a prospective study
to evaluate the specific normalization rates of several
perfusion-related variables in a cohort of consecutive sep-
tic shock patients subjected to protocolized resuscitation
and multimodal perfusion assessment. We a priori de-
cided to include only ultimately hospital-surviving patients
for analysis to provide a relevance perspective to persistent
abnormalities after initial resuscitation.
Methods
Setting
We conducted a prospective observational study from
July 2011 to November 2012 in a mixed 16-bed ICU at
our university hospital. The institutional review board of
our university approved this study and waived the need
of an informed consent because of the observational na-
ture of the study (Comité de Etica en Investigación,
Facultad de Medicina, Pontificia Universidad Católica de
Chile; approval number 11-113).
Patient selection
We included all consecutive adult patients admitted to
the ICU with septic shock diagnosis according to the
2001 consensus definition [14], with a basal arterial lac-
tate >2 mmol/L and full commitment for resuscitation.
Protocol and measurements
Patients were studied for the first 24 h following initi-
ation of ICU-based resuscitation and were followed until
death or hospital discharge. Clinical and demographic
data and severity scores [15,16] were collected for each pa-
tient at baseline (at inclusion = 0 h).The following measurements as part of a multimodal
perfusion assessment were obtained at baseline and at 2,
6, and 24 h after starting ICU resuscitation:
1. Macro-hemodynamic variables: mean arterial
pressure (MAP), heart rate, norepinephrine (NE) or
vasoactive drug doses, central venous pressure
(CVP), pulse pressure variation (%), and pulmonary
artery catheter-derived values (when in place). Fluid
administration was also registered at each predefined
time-point.
2. Metabolic-related perfusion variables: ScvO2, arterial
lactate and P(cv-a)CO2.
3. Peripheral perfusion was assessed with the capillary
refill time (CRT) (normal values ≤4.0 s) [17].
In a subgroup of patients who arrived within the first
2 h of onset of septic shock and were already in mechan-
ical ventilation, we performed also the following micro-
circulatory and micro-oxygenation assessments:
1. Thenar muscle oxygen saturation (StO2) was
measured by a tissue spectrometer (InSpectra Model
650, Hutchinson Technology, Minneapolis, MN,
USA) [18]. A value ≥75% was considered as normal
for this protocol. A vascular occlusion test (VOT)
was performed as described elsewhere [19]. During
the reperfusion phase of the VOT, the recovery
slope of the StO2 signal was registered and
calculated with a software (InSpectra V3-03, Hutch-
inson Technology, MN, USA) and expressed in per-
centage per second (values >3.5%/s were considered
as normal for this study based on our own data in
healthy volunteers (data not shown)).
2. Microcirculatory-derived variables: sublingual
microcirculation was assessed with sidestream dark
field video microscopy imaging (Microscan® for
NTSC, MicroVision Medical, Amsterdam, the
Netherlands). Image acquisition and analysis were
performed following recent recommendations of a
consensus conference [20]. A trained independent
investigator performed image analysis in all cases,
and these data were not disclosed to the attending
physicians or considered for management.
Parameters considered for this study were
proportion of perfused vessels (PPV; values ≥90%
were considered as normal); perfused vessel density
(PVD; values ≥14 n/mm were considered as
normal); and microcirculatory flow index (MFI;
values ≥2.5 were considered as normal).
All patients were managed according to a local algo-
rithm [21] aimed at macrohemodynamic stabilization
and improvement of hypoperfusion abnormalities (both
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plementation of adequate maneuvers for source control.
The main strategy to improve oxygen transport/oxygen
consumption unbalance was preload optimization. For
this purpose, the algorithm included early fluid loading,
followed by NE as needed to maintain a MAP >65 mmHg.
Further fluid resuscitation was guided by dynamic predic-
tors (pulse pressure variation) in patients under mechan-
ical ventilation, except in patients with atrial fibrillation
[22]. To assess pulse pressure variation in patients with
acute respiratory distress syndrome, we transiently in-
creased tidal volume to 8 mL/kg. A pulmonary artery
catheter was placed in patients with high NE requirements
(>0.3 mcg/kg/min) or past medical history of cardiac
disease. In patients with atrial fibrillation and with a pul-
monary artery catheter in place, volume administration
was guided by a Starling curve approach in which progres-
sive fluid boluses were administered until reaching a plat-
eau in cardiac index. In patients with spontaneous
breathing, fluid resuscitation was guided by central venous
pressure criteria as suggested by current guidelines [4].
Dobutamine was restricted to patients with cardiac index
<2.2 L/min/m2 in whom attending physicians had ruled-
out hypovolemia as the cause of persistent hypoperfusion.
Arterial hemoglobin oxygen saturation was maintained at
>90%, and hemoglobin concentrations at 8 g/dl or higher
to optimize arterial oxygen content. Mechanical ventila-
tion settings were adjusted according to current recom-
mendations [4]. Intra-abdominal pressure was monitored
and treated according to recent recommendations [23].Statistical analysis
Categorical data were analyzed with chi-square or Fish-
er's exact test when appropriate. Repeated measures
were analyzed with Friedman test with Bonferroni post-
hoc correction. All data are presented as medians and
25 to 75 interquartile ranges. We performed trend esti-
mations of different perfusion and microcirculatory vari-
ables computing the average ranks for each variable
using Pearson's correlation coefficient as described by
Cuzick [24]. We also performed a normalization proced-
ure for lactate, P(cv-a)CO2, and CRT values to rescaling
them in order to allow comparison of these parameters'
relative changes in specific time periods. For each vari-
able, the highest normal value was taken, and each indi-
vidual value was divided by it. Hence, medians and
interquartile ranges were plotted. Fractional polynomials
analyses were done to model realistic fitting curves for
each parameter trend. All reported p values are two-
sided, with a significant alpha level at 5%. SPSS 17 (SPSS
Inc., Chicago, IL, USA) and Stata 12 (StataCorp LP,
College Station, TX, USA) statistical packages were used
for analyses.Results
One hundred and four patients were admitted with a
diagnosis of septic shock during the 18-month period,
with a hospital mortality of 19% (N = 20).
Within this group, 84 were discharged alive from the
hospital and constitute our definitive study group. Thus,
data regarding non-survivors were not considered for
final analysis and are only provided in Additional file 1:
Table S1. Basal demographic, clinical, and physiological
data and severity scores of the whole population and the
84 survivors are provided in Table 1. The main septic
sources were abdominal (n = 45), pulmonary (n = 23),
urinary tract (n = 8), and others, including soft tissue
and catheter sources (n = 8). Sixteen patients were
admitted directly from the operating room.
Patients received 1,750 [640 to 2,400] mL of crystal-
loids in the pre-ICU setting after meeting septic shock
criteria. The rate of fluid administration tended to de-
crease over time during ICU resuscitation. A total of
1,150 [600 to 1,600] mL of crystalloids were adminis-
tered during the first 2 h, 980 [510 to 1,410] mL from 3
to 6 h, and 1,020 [290 to 2,400] mL from 7 to 24 h of
ICU-based resuscitation. A pulmonary artery catheter
was placed in 38 patients. Basal cardiac index and
pulmonary arterial occlusion pressure were 3.1 [2.5 to 3.9]
L/min/m2 and 17 [12 to 23] mmHg, respectively. Dobuta-
mine was used in ten patients. Basal and 24-h intra-
abdominal pressures were 13 [9 to 17] and 13 [8 to 15]
mmHg, respectively.
By definition, all patients started ICU-based resuscita-
tion with an abnormal lactate as compared to only 8, 31,
32, and 39 patients with abnormal ScvO2, StO2, P(cv-a)
CO2, and CRT values, respectively. Medians values for
individual macrohemodynamic and perfusion variables
at different time-points in patients with abnormal values
at baseline are shown in Table 2. Lactate decreased sig-
nificantly from 0 to 6 h (4.0 [3.0 to 4.9] vs. 2.7 [2.2 to
3.9] mmol/L; p < 0.01).
When analyzing the time-trend changes of lactate, P
(cv-a)CO2, and CRT values, a biphasic curve could be
drawn (Figure 1) where a rapid decrease in every vari-
able during the first 6 h was followed by a slower decay
thereafter.
Medians values for microcirculatory variables and the
percentage of normalization for lactate, P(cv-a)CO2, CRT,
and microcirculatory variables at different time-points for
the subgroup of patients arriving within the first 2 h of
septic shock are shown in Table 3 and Figure 2, respect-
ively. In these patients, lactate levels dropped to normal in
52% of the patients at 24 h. During follow-up of the 40
remaining patients with persistent hyperlactatemia at
24 h, 24 normalized lactate at 48 h, ten at 72 h, and six up
to the seventh day. In contrast, microcirculatory variables
remained abnormal in the majority of the patients, even at
Table 1 General characteristics of the study population
Parameters Total patients Survivors without MC Survivors with MC p value between survivors
Number 104 53 31
Age (years) 66 [56 to 75] 63 [52 to 71] 67 [56 to 76] 0.4
Male/female (%) 45/55 47/53 39/61 0.3
APACHE II 23 [19 to 26] 23 [18 to 27] 24 [19 to 27] 0.5
Basal SOFA 10 [8 to 13] 10 [8 to 13] 10 [8 to 13] 0.9
24 h SOFA 10 [7 to 12] 10 [7 to 12] 11 [10 to 13] 0.6
Length of hospital stay (days) 23 [15 to 35] 24 [16 to 36] 24 [15 to 43] 0.8
Length of ICU stay (days) 11 [7 to 17] 11 [7 to 25] 10 [7 to 16] 0.5
MV duration (days) 8 [5 to 15] 9 [5 to 15] 8 [5 to 14] 0.4
Basal NE requirements (mcg/kg/min) 0.11 [0.03 to 0.30] 0.10 [0.04 to 0.28] 0.16 [0.03 to 0.34] 0.4
Basal lactate (mmol/L) 4.0 [3.0 to 4.9] 4.2 [3.0 to 5.3] 4.0 [2.8 to 4.9] 0.9
Values are expressed as median [interquartile range] or percentage. MC, microcirculatory assessment; APACHE II, acute physiology and chronic health evaluation II;
SOFA, sequential organ failure assessment; ICU, intensive care unit; MV, mechanical ventilation; NE, norepinephrine.
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vs. 11 [8 to 15]; p = 0.2) or NE requirements (0.01 [0 to
0.04] vs. 0.17 [0 to 0.24]; p = 0.16) was observed between
patients that had normalized lactate or not at 24 h.
Discussion
Perfusion-related variables exhibit markedly different
normalization rates in septic shock survivors, most of
them exhibiting a biphasic response with an initial rapid
improvement, followed by a much slower trend there-
after. This fact should be taken into account to deter-
mine the most appropriate criteria to stop resuscitation
opportunely and avoid the risk of over-resuscitation.
Central venous oxygen saturation, P(cv-a) CO2, and
CRT values were already normal in the majority of pa-
tients at ICU admission after some previous volumeTable 2 Evolution of different perfusion and hemodynamic p
Perfusion parameters Number of patients with altered
baseline values
Baseline
Lactate (mmol/L) 84 4.0 [3.0 to
P(cv-a)CO2 (mmHg) 34 8 [7 to 9]
CRT (s) 43 6 [5 to 8]
ScvO2 (%) 8 62 [58 to 6
Hemodynamic
parameters
Number of patients assessed Baseline
CI (L/min/m2) 38 3.1 [2.5 to
Pulse pressure variation (%) 63 6 [3 to 8]
CVP (mmHg) 84 13 [9 to 17
MAP (mm Hg) 84 73 [67 to 7
NE dose (mcg/kg/min) 84 0.11 [0.04
IAP (mmHg) 72 12 [9 to 15
Values are expressed as median [interquartile range]. aComparison within group of variab
gradient; CRT, capillary refill time; ScvO2, central venous oxygen saturation; CI, cardiac ind
IAP, intra-abdominal pressure.loading, and it appears that these variables are particu-
larly responsive to DO2 increasing maneuvers. In a
previous study, ScvO2, increased from 49% to 77% in
septic shock patients subjected to early aggressive DO2
optimization [3]. The sensitivity of ScvO2 to pre-ICU
fluid loading probably explains the almost negligible in-
cidence of low ScvO2 values in the ICU setting [25,26].
CRT may also improve rapidly after fluid resuscitation,
and we found that normality of CRT values increased
from 46% to 70% after 2 h of resuscitation. Changes in
ScvO2, P(cv-a) CO2, and CRT appeared to become
slower after 6 h, eventually representing the influence of
non-flow dependent mechanisms on the remaining ab-
normalities [6,27,28].
The case of hyperlactatemia is paradigmatic. Although
tissue hypoperfusion has been traditionally consideredarameters in a cohort of 84 hospital survivors
2 h 6 h 24 h p valuea
4.9] 3.4 [2.4 to 4.2] 2.8 [2.0 to 3.8] 1.8 [1.4 to 2.5] <0.001
6 [5 to 8] 5 [3 to 7] 4 [3 to 6] <0.001
4 [3 to 5] 3 [2 to 6] 2 [2 to 4] 0.001
7] 65 [60 to 69] 71 [70 to 74] 74 [70 to 79] 0.001
2 h 6 h 24 h p valuea
3.9] 3.5 [2.9 to 4.6] 3.2 [2.6 to 3.8] 2.8 [2.4 to 4.1] NS
5 [2 to 8] 6 [2 to 8] 5 [4 to 9] NS
] 14 [10 to 16] 14 [10 to 16] 14 [11 to 17] NS
9] 71 [68 to 74] 71 [68 to 74] 72 [70 to 77] NS
to 0.3] 0.18 [0.06 to 0.31] 0.17 [0.07 to 0.35] 0.05 [0 to 0.23] NS
] 11 [9 to 13] 12 [9 to 12] 11 [8 to 14] NS
les was made with non-parametric trend. p(cv-a)CO2, central venous to arterial pCO2
ex; CVP, central venous pressure; MAP, mean arterial pressure; NE, norepinephrine;
Figure 1 Time-trend changes for selected perfusion parameters after normalization showing a biphasic recovery trend (see statistical
analysis): A, lactate; B, capillary refill time (CRT); C, central venous-arterial pCO2 gradient (P(cv-a)CO2).
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creasing evidence for concomitant non-hypoxic and
thus, non-flow dependent mechanisms [28,29] that may
influence the time course of lactate recovery rate. The
distinction between these two scenarios (flow-responsivevs. non-flow dependent hyperlactatemia) should strongly
impact the therapeutic approach [13].
As an example, treatment of the latter with sustained
efforts aimed at increasing DO2 could lead to detrimen-
tal effects of excessive fluids or inotropes. In our study,
Table 3 Evolution of microcirculatory parameters in a cohort of 31 hospital survivors
Perfusion parameters Number of patients with
altered baseline values
Baseline 2 h 6 h 24 h p valuea
PPV (%) 30 69 [62 to 75] 70 [68 to 78] 71 [67 to 79] 77 [68 to 83] 0.04
MFI (score) 28 1.9 [1.5 to 2.2] 2.0 [1.6 to 2.2] 2.1 [1.8 to 2.3] 2.2 [2.0 to 2.5] 0.003
StO2 (%) 8 72 [65 to 74] 73.5 [71 to 76] 75.5 [69 to 84] 77 [68 to 85] NS
StO2 recovery slope (%/s) 23 1.72 [0.6 to 2.0] 1.76 [0.7 to 2.7] 1.70 [1.2 to 2.8] 2.0 [1.6 to 3.1] 0.055
Values are expressed as median [interquartile range]. aComparison within group of variables was made with non-parametric trend. PPV, proportion of perfused
vessels; MFI, microcirculatory flow index; PVD, perfused vessel density; StO2, tissue oxygen saturation.
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basal median values during the first 6 h of resuscitation
associated with a rapid normalization of other metabolic
and peripheral perfusion parameters (Figure 1). How-
ever, further decrease in lactate was very slow since lac-
tate of 48% of patients was normalized beyond the first
ICU day. This behavior may raise a doubt whether these
patients would have benefited from more volume load-
ing. Nevertheless, as negative dynamic predictors or a
plateau Starling curve discarded further fluid responsive-
ness, we had no objective evidence that persistent hyper-
lactatemia could be addressed to ongoing flow dependent
mechanisms. Thus, it appears that lactate decrease can be
characterized by a biphasic evolution: an early rapid re-
sponse followed by a later slower recovery trend poten-
tially explained by non-flow dependent mechanisms.
Indeed, a recently published therapeutic algorithm focused
lactate-driven resuscitation exclusively in the first 8 h ofFigure 2 Percentage of abnormal values for several perfusion and mi
of these parameters at different time-points during the first 24 h of intensive
PPV, proportion of perfused vessels; MFI, microvascular flow index; P(cv-a)CO2ICU management with a significant favorable impact on
outcome [30].
In the present study, sublingual microcirculatory vari-
ables exhibited the slowest recovery rate. Moreover,
since concomitant clinical and metabolic perfusion vari-
ables were already normal in the great majority of our
patients, it appears as highly unlikely that persistent micro-
circulatory abnormalities may respond to additional fluids
or DO2 optimization maneuvers after 24 h of resuscitation.
In fact, fluid loading after 48 h of sepsis failed to improve
microcirculatory derangements in a recent report [31]. The
time-course of microcirculatory recovery during septic
shock resuscitation may also follow a biphasic pattern with
an early apparently flow-responsive phase [32,33]. How-
ever, further improvements appear to be much slower with
full recovery taking several days [8,34]. The recovery slope
of StO2 after a VOT maneuver was moderately abnormal
in all patients, and like microcirculatory derangements, itcrocirculatory parameters in septic shock survivors. The evolution
care unit-based resuscitation is presented. PVD, perfused vessel density;
, central venous-arterial pCO2 gradient; CRT, capillary refill time.
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improvement at 24 h. Taken together, our current and
previous data suggest that persistent microcirculatory
abnormalities after 24 h of resuscitation may represent
different pathogenic mechanisms not responsive to DO2
increasing maneuvers.
How can we conceptualize our results? The critical
decision to stop resuscitation is complex and should
probably be taken after a multimodal perfusion assess-
ment has been performed. The normalization of some
variables such as ScvO2, lactate, or CRT is clearly a good
signal, but eventually their normalization trend is more
important than absolute values at certain periods. In
practical terms, resuscitation would have been stopped
at admission in 90% of these patients by using the single
criterion of a normal ScvO2 but only in 52% of patients
at 24 h by using a normal lactate criterion. Our study
was not designed to establish which criterion is better,
but it does suggest that the length of septic shock resus-
citation may vary dramatically depending on the selected
perfusion goal and that the different potential targets are
not equivalent or interchangeable as suggested by a re-
cent guideline [4]. Since ours is only a hypothesis-
generating study, these findings should be explored and
confirmed in future studies, since as mentioned before
an excess in resuscitation efforts may lead to severe side
effects.
Finally, due to the complexity of the pathogenic mech-
anisms influencing each of the perfusion variables, and
of their dynamic characteristics, it is clear that treatment
of septic shock may also be guided by the presence of
comorbidities, adequacy of source control, and the de-
gree of systemic inflammation, among others.
We acknowledge several potential limitations of our
study. This cohort exhibited a low mortality rate. There-
fore, our findings may not be universally extrapolated.
However, several recent studies report a mortality of
around 20% in septic shock patients undergoing early re-
suscitation, especially when the main source is abdom-
inal [35-37]. Second, the study period may be considered
not long enough and the selected time points are arbi-
trary. Third, this is a single center study that limits its ap-
plication to other settings and centers. Fourth, due to the
design of this study, we cannot determine if changes in
perfusion variables over time can be ascribed to the nat-
ural evolution of disease or to the effects of some specific
treatment. Fifth, although our findings suggest that the
length of the resuscitation process could vary dramatically
according to the selected perfusion goal, we do not know
if this effectively leads to over-resuscitation in some cases
since our study was not designed to establish this point.
Finally, since only surviving patients compose our cohort,
we know that the main endpoint of any septic shock re-
suscitation strategy was successfully achieved. However,we do not know if additional resuscitation could have fur-
ther reduced morbidity. Nevertheless, the lack of differ-
ence in 24-h SOFA scores or NE requirements between
patients who normalized lactate vs. those who did not
makes this possibility unlikely. Furthermore, as dynamic
predictors of fluid responsiveness were persistently nega-
tive, there is no evidence that additional resuscitation
could have benefited secondary outcomes, especially con-
sidering controversial data concerning other potential
therapies such as dobutamine or nitroglycerine [38,39].
Conclusions
In conclusion, these results demonstrate that perfusion-
related variables exhibit markedly different normalization
rates in septic shock survivors, most of them showing a
biphasic response with an initial rapid improvement,
followed by a much slower trend thereafter. The length of
septic shock resuscitation may vary dramatically depend-
ing on the selected perfusion goal. This fact should be
taken into account to determine the most appropriate
criteria to stop resuscitation opportunely and avoid the
risk of over-resuscitation.
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